Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction

Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium.

Guardado en:
Detalles Bibliográficos
Autores principales: Sarah McLaughlin, Brian McNeill, James Podrebarac, Katsuhiro Hosoyama, Veronika Sedlakova, Gregory Cron, David Smyth, Richard Seymour, Keshav Goel, Wenbin Liang, Katey J. Rayner, Marc Ruel, Erik J. Suuronen, Emilio I. Alarcon
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/87f2d71678a14732bc74e04f815a25a6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:87f2d71678a14732bc74e04f815a25a6
record_format dspace
spelling oai:doaj.org-article:87f2d71678a14732bc74e04f815a25a62021-12-02T15:35:34ZInjectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction10.1038/s41467-019-12748-82041-1723https://doaj.org/article/87f2d71678a14732bc74e04f815a25a62019-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-12748-8https://doaj.org/toc/2041-1723Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium.Sarah McLaughlinBrian McNeillJames PodrebaracKatsuhiro HosoyamaVeronika SedlakovaGregory CronDavid SmythRichard SeymourKeshav GoelWenbin LiangKatey J. RaynerMarc RuelErik J. SuuronenEmilio I. AlarconNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Sarah McLaughlin
Brian McNeill
James Podrebarac
Katsuhiro Hosoyama
Veronika Sedlakova
Gregory Cron
David Smyth
Richard Seymour
Keshav Goel
Wenbin Liang
Katey J. Rayner
Marc Ruel
Erik J. Suuronen
Emilio I. Alarcon
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
description Many patients, following therapy for acute myocardial infarction, develop adverse cardiac remodelling. Here the authors present injectable recombinant human collagen 10 of 10 type I and III matrices that are able to limit adverse remodelling and improve function of the myocardium.
format article
author Sarah McLaughlin
Brian McNeill
James Podrebarac
Katsuhiro Hosoyama
Veronika Sedlakova
Gregory Cron
David Smyth
Richard Seymour
Keshav Goel
Wenbin Liang
Katey J. Rayner
Marc Ruel
Erik J. Suuronen
Emilio I. Alarcon
author_facet Sarah McLaughlin
Brian McNeill
James Podrebarac
Katsuhiro Hosoyama
Veronika Sedlakova
Gregory Cron
David Smyth
Richard Seymour
Keshav Goel
Wenbin Liang
Katey J. Rayner
Marc Ruel
Erik J. Suuronen
Emilio I. Alarcon
author_sort Sarah McLaughlin
title Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
title_short Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
title_full Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
title_fullStr Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
title_full_unstemmed Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
title_sort injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/87f2d71678a14732bc74e04f815a25a6
work_keys_str_mv AT sarahmclaughlin injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT brianmcneill injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT jamespodrebarac injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT katsuhirohosoyama injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT veronikasedlakova injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT gregorycron injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT davidsmyth injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT richardseymour injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT keshavgoel injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT wenbinliang injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT kateyjrayner injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT marcruel injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT erikjsuuronen injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
AT emilioialarcon injectablehumanrecombinantcollagenmatriceslimitadverseremodelingandimprovecardiacfunctionaftermyocardialinfarction
_version_ 1718386545367449600